Get to know our clinical trials
Clinical trial to evaluate the efficacy and safety of two concentrations (1000 DPP/mL and 3000 DPP/mL) of depigmented polymerized allergen extracts of Depigoid Grass-Mix / Depigoid FORTE Grass-Mix compared with placebo in patients with allergic rhinoconjunctivitis, with or without controlled asthma, due to clinically relevant sensitization to grass pollen.
THE OBJECTIVE OF THIS STUDY IS TO COLLECT DATA ON THE SAFETY OF THE INVESTIGATIONAL STUDY MEDICATION AND TO DETERMINE HOW WELL IT WORKS IN TREATING GRASS POLLEN ALLERGY.
Status
In recruitment
headquarters
Pamplona
Technical Summary
- CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF TWO CONCENTRATIONS (1000 DPP/ML AND 3000 DPP/ML) OF DEPIGMENTED POLYMERIZED ALLERGEN EXTRACTS OF DEPIGOID GRASS-MIX / DEPIGOID FORTE GRASS-MIX COMPARED WITH PLACEBO IN PATIENTS WITH ALLERGIC RHINOCONJUNCTIVITIS, WITH OR WITHOUT CONTROLLED ASTHMA, DUE TO CLINICALLY RELEVANT SENSITIZATION TO GRASS POLLEN.
- Code EudraCT: 2025-521736-10-00
- Protocol number: 0600-PG-PSC-218
- Promoter: Laboratorios Leti S.L
- Molecule/Drug: Depigoid Grass-Mix / Depigoid FORTE Grass-Mix
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.